Microbiome Giredestrant Outperforms Standard-of-Care Endocrine Therapy in Breast CancerBy adminDecember 10, 20250 Credit: Christoph Burgstedt/Getty Images Results from the Phase III lidERA clinical trial show that giredestrant, an adjuvant therapy for early-stage…
DNA & Genetics Macrophage-Blocking Antibodies Help Overcome Breast Cancer Endocrine ResistanceBy adminNovember 5, 20250 Credit: Artur Plawgo/Getty Images Preclinical studies by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School…
